Kamada Ltd. KMDA
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Kamada Ltd. is a biopharmaceutical company specializing in the development, production, and marketing of specialty plasma-derived protein therapeutics. Its primary purpose is to provide innovative medical solutions for unmet clinical needs, particularly in the fields of immunology, respiratory diseases, and critical ca…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryIsrael
Employees462
TickerKMDA
Statistics
Market Cap$427.5M
Revenue (TTM)$180.5M
Net Income$20.2M
Net Margin11.2%
EPS$0.35
P/E21.26
P/S2.37
P/B1.65
EV/EBITDA9.11
ROE8.0%
Dividend Yield13.44%
Price$7.41
Data: Twelve Data · Revenue = mcap / P/S